Moxonidine

莫索尼定

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameMoxonidine
Drug Alias Name莫索尼啶PhysiotensNormoxinNucyntMoxon +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImidazoline I1 receptors agonists
TargetsImidazoline I1 receptors
Therapy Area/IndicationsObesityInsulin ResistanceHypertension +[4] 
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyIndia +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesVanderbilt University Medical Center
Inactive CompaniesNational Heart, Lung, And Blood Institute (Nhlbi)Solvay Pharmaceuticals
Active IndicationsHypertensionPostural Orthostatic Tachycardia Syndrome
Inactive IndicationsObesityInsulin Resistance

Other Information

ATC CodeC02AC05
Related LinksWikipediaDrugBankKEGG